You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

118 search results for: quality of life

La DA en pacientes pediátricos: Experiencia con Dupilumab
expert video

La DA en pacientes pediátricos: Experiencia con Dupilumab

Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Marta Feito, dermatóloga en el Hospital Universitario La Paz, presentó su experiencia con Dupilumab.
View more
ERS 2024 | Perspectives From the Evolving Biologic Landscape in COPD
expert video

ERS 2024 | Perspectives From the Evolving Biologic Landscape in COPD

Pulmonology
Professor Alberto Papi presents the latest clinical data on current and emerging biologics for COPD with type 2 inflammation.
View more
CRSwNP: A Chronic Type 2 Inflammatory Disease
expert video

CRSwNP: A Chronic Type 2 Inflammatory Disease

Rhinology
Prof. Peter Hellings describes how type 2 inflammation drives CRSwNP.
View more
Partnering With Patients for Clinical Decision-Making in CRSwNP
expert video

Partnering With Patients for Clinical Decision-Making in CRSwNP

Rhinology
Profs. Wytske Fokkens and Joaquim Mullol investigate the importance of partnering with patients with CRSwNP in clinical decision-making.
View more
Scientific Advances in EoE and Impact on Clinical Practice
expert video

Scientific Advances in EoE and Impact on Clinical Practice

Gastroenterology
Expert gastroenterologist Dr. Evan Dellon highlights research and scientific advances in EoE and their impact on clinical practice.
View more
Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
expert video

Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?

Rhinology
This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.
View more
What Do We Know About Type 2 Inflammation in COPD?
expert video

What Do We Know About Type 2 Inflammation in COPD?

Pulmonology
Join global expert Dr. Michael Wechsler as he discusses type 2 inflammation in COPD.
View more
Treatment Goals, Current and Emerging Therapies in CSU
expert video

Treatment Goals, Current and Emerging Therapies in CSU

Dermatology
Drs. Maurer and Ensina delve into their thoughts on the latest treatment goals and emerging therapies for CSU in this illuminating interview.
View more
Early Intervention in AD: Latest Clinical and Real-world Data
expert video

Early Intervention in AD: Latest Clinical and Real-world Data

Dermatology
Highlights from ESPD 2023 ADVENT: Reviewing the current treatment landscape and the potential for early intervention in pediatric atopic dermatitis.
View more
Targeting Type 2 Inflammation: ​Skin Barrier Normalization​
expert video

Targeting Type 2 Inflammation: ​Skin Barrier Normalization​

Dermatology
Highlights from ESPD 2023 ADVENT: Uncovering how type 2 inflammation influences skin barrier dysfunction in atopic dermatitis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SpainChange country/region